What happens after 3 years. Sounds like we stop manufacturing, which I guess means zero revenue?
Sounds like we sold the entire thing but get to manufacture for 3 years. Gives some good upside if sales take off, but I would have liked an ongoing royalty payment.
Guess it is much better than going broke!! Hopefully we can ditch our expensive sales team as well. The $22m could last ages
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-104
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M | |||
| Open | High | Low | Value | Volume |
| $15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 297 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 1300 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |